Endeavor BioMedicines Presents New Clinical Findings From Post Hoc Analysis of Phase 2a Clinical Trial Evaluating ENV-101 in Patients with Idiopathic Pulmonary Fibrosis Findings presented at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results